Cognitive research
A short peptide studied for attention, mental stamina, and neuroprotection, best known for raising BDNF.
Semax is a seven-amino-acid peptide derived from a fragment of ACTH, a hormone your body already produces. The fragment was modified so that it keeps the neurological activity while dropping the hormonal effects. It is typically used intranasally, which matters more than it sounds: the nasal route gives peptides a direct path toward the brain rather than making them survive digestion and the bloodstream first.
Two things happen at once. Semax raises BDNF — brain-derived neurotrophic factor, the growth factor behind the brain's ability to form and maintain connections. And it increases dopamine signaling in the regions governing focus and drive. That combination is why people describe the effect as clear-headed engagement rather than the wired, brittle feeling stimulants produce.
Semax upregulates BDNF and NGF expression, supporting synaptic plasticity and neuronal survival. It modulates dopaminergic transmission in the striatum and prefrontal cortex, in part by slowing dopamine degradation rather than forcing release — which explains the absence of a crash. Downstream it activates cAMP-PKA and MAPK/ERK cascades, increasing protein synthesis, and shows measurable antioxidant and anti-inflammatory activity with stabilizing effects on mitochondrial function. Intranasal administration exploits nose-to-brain transport, bypassing the blood-brain barrier; plasma half-life is short (roughly 20–25 minutes) while the functional effects outlast it considerably.
Onset is quick — commonly within half an hour of an intranasal dose. The acute effect is subtle and easy to miss if you are expecting a stimulant: most people notice it as the absence of afternoon drift rather than a surge. The neurotrophic effects — the part that may matter more — accumulate over weeks and are not something you feel day to day.
Every page on this site includes this section. If a source only tells you what something does, you are reading marketing.
Reported tolerability is good and the adverse-event profile in published use is mild — nasal irritation is the most common complaint. It is not FDA- or EMA-approved. Anyone taking dopaminergic or psychiatric medication should treat the interaction question seriously and involve their prescriber, since the mechanism overlaps. Not appropriate during pregnancy or breastfeeding, or for minors, given the absence of data.
Semax is one where source quality is unusually visible in use — degraded or underdosed product simply does nothing. Look for third-party purity testing with a batch-matched certificate of analysis, and expect it to be shipped and stored cold.
No. It is approved in Russia for specific neurological indications and remains investigational in the United States and Europe.
No. It affects dopamine signaling but does not act like amphetamine-class stimulants — there is no acute surge, and users do not report a crash or tolerance in the same way.
They address different problems. Semax targets focus and drive; Selank targets stress and anxiety. They are frequently discussed together because most demanding weeks involve both failure modes.
General education only goes so far. If you want help deciding whether this is relevant to your goals, history, and current labs, schedule a consultation with the Bearing team.
Request a Consultation